Atlas Trials

Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma

Clinical trial NCT03382886 · TERMINATED

Trial details

NCT number
NCT03382886
Sponsor
University of Utah
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2018-04-11
Primary completion
2018-07-26
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.